Greif M, Arnoldt T, von Ziegler F, et al. Lipoprotein (a) is independently correlated with coronary artery calcification[J].Euro J Internal Med, 2013, 24(1): 75-79.
陈俊华, 张存新. 冠心病患者胱抑素 C 与 SYNTAX 评分的相关性研究[J].中华老年心脑血管病杂志, 2014, 16(11): 1171-1174.
[4]
Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease[J].Clinical chemistry, 1994, 40(1): 18-23.
Horsfall LJ, Nazareth I, Petersen I. Cardiovascular events as a function of serum bilirubin levels in a large statin-treated cohort[J].Circulation, 2012, 126(22): 2556-2564.
[8]
Kalkan GY, Gür M, Baykan AO, et al. Serum bilirubin level and aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease[J].Angiology, 2013, 7(6): 316-321.
[9]
Breimer LH, Wannamethee G, Ebrahim S, et al. Serum bilirubin and risk of ischemic heart disease in middle-aged British men[J].Clinical chemistry, 1995, 41(10): 1504-1508.
[10]
Kamstrup PR, Benn M, Tybj？rg-Hansen A, et al. Extreme lipoprotein (a) levels and risk of myocardial infarction in the general population the Copenhagen City Heart Study[J].Circulation, 2008, 117(2): 176-184.
[11]
Maranh？o RC, Carvalho PO, Strunz CC, et al. Lipoprotein (a): structure, pathophysiology and clinical implications[J].Arq Bras Cardiol, 2014, 103(1): 76-84.
[12]
Bengtsson E, To F, Grubb A, et al. Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice[J].Atherosclerosis, 2005, 180(1): 45-53.
[13]
Ganda A, Magnusson M, Yvan-Charvet L, et al. Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis[J].Circulation, 2013, 127(9): 988-996.
[14]
Kiyosue A, Hirata Y, Ando J, et al. Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease[J].Circulation J, 2010, 74(11): 2441-2447.
